Hepatitis C virus (HCV) is a major leading cause of hepatocellular carcinoma (HCC). HCV-induced hepatocarcinogenesis is a multistep process resulting from a combination of pathway alterations that are either caused directly by viral factors or immune mediated as a consequence of a chronic state of inflammation. Host genetic variation is now emerging as an additional element that contribute to increase the risk of developing HCC. The advent of direct-acting antiviral agents foresees a rapid decline of HCC rate in HCV patients. However, a full understanding of the HCV-mediated tumourigenic process is required to elucidate if pro-oncogenic signatures may persist after virus clearance, and to identify novel tools for HCC prevention and therapy. In this review, we summarize the current knowledge of the molecular mechanisms responsible for HCV-induced hepatocarcinogenesis. (C) 2016 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.

Vescovo, T., Refolo, G., Vitagliano, G., Fimia, G.m., Piacentini, M. (2016). Molecular mechanisms of hepatitis C virus–induced hepatocellular carcinoma. CLINICAL MICROBIOLOGY AND INFECTION, 22(10), 853-861 [10.1016/j.cmi.2016.07.019].

Molecular mechanisms of hepatitis C virus–induced hepatocellular carcinoma

Piacentini M.
2016-01-01

Abstract

Hepatitis C virus (HCV) is a major leading cause of hepatocellular carcinoma (HCC). HCV-induced hepatocarcinogenesis is a multistep process resulting from a combination of pathway alterations that are either caused directly by viral factors or immune mediated as a consequence of a chronic state of inflammation. Host genetic variation is now emerging as an additional element that contribute to increase the risk of developing HCC. The advent of direct-acting antiviral agents foresees a rapid decline of HCC rate in HCV patients. However, a full understanding of the HCV-mediated tumourigenic process is required to elucidate if pro-oncogenic signatures may persist after virus clearance, and to identify novel tools for HCC prevention and therapy. In this review, we summarize the current knowledge of the molecular mechanisms responsible for HCV-induced hepatocarcinogenesis. (C) 2016 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.
2016
Pubblicato
Rilevanza internazionale
Recensione
Esperti anonimi
Settore BIO/06 - ANATOMIA COMPARATA E CITOLOGIA
English
Con Impact Factor ISI
Genetic variants; Hepatitis C virus; Hepatocellular carcinoma; Hepatocyte apoptosis; Hepatocyte autophagy; Hepatocyte proliferation; Immunomediated liver alterations; Steatohepatitis; Antiviral Agents; Carcinogenesis; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Hepacivirus; Hepatitis C; Humans; Liver Neoplasms
Vescovo, T., Refolo, G., Vitagliano, G., Fimia, G.m., Piacentini, M. (2016). Molecular mechanisms of hepatitis C virus–induced hepatocellular carcinoma. CLINICAL MICROBIOLOGY AND INFECTION, 22(10), 853-861 [10.1016/j.cmi.2016.07.019].
Vescovo, T; Refolo, G; Vitagliano, G; Fimia, Gm; Piacentini, M
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/233257
Citazioni
  • ???jsp.display-item.citation.pmc??? 62
  • Scopus 113
  • ???jsp.display-item.citation.isi??? 100
social impact